No Association Between Functional Polymorphisms in COMT and MTHFR and Schizophrenia Risk in Korean Population

키워드

참고문헌 (37)

1. Tsuang M., "Schizophrenia: genes and environment", Biol Psychiatry, 47, pp.210~220 (2000)
2. Owen MJ, "Schizophrenia in Psychiatric genetics & genomics", pp.247~266 (2002), Oxford University Press
3. Egan MF, "Effect of COMT Val108", 158Met genotype on frontal lobe function and risk for schizophrenia, 2001, pp.98, 6917~6922
4. Joober R, "Catechol-O-methyltransferase Val-108", 158-Met gene variants associated with performance on the Wisconsin Card Sorting Test, 2002, pp.59, 662~663
5. Barnett JH, "Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls", Mol Psychiatry, 12, pp.502~509 (2007)
6. Fan JB, "Catechol-O-methyltransferase gene Val", Met functional polymorphism and risk of schizophrenia: a large-scale association study plus metaanalysis, 2005, pp.57, 139~144
7. Munafò MR, "Lack of association of the COMT (Val158", 108 Met) gene and schizophrenia: a meta-analysis of case-control studies, 2005, pp.10, 765~770
8. Shifman S, "A highly significant association between a COMT haplotype and schizophrenia", Am J Hum Genet, 71, pp.1296~1302 (2002)
9. Bray NJ, "A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain", Am J Hum Genet, 73, pp.152~161 (2003)
10. Goyette P, "Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification", Nat Genet, 7, pp.195~200 (1994)
11. van der Put NM, "A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects?", Am J Hum Genet, 62, pp.1044~1051 (1998)
12. Lievers KJ, "A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk", J Mol Med, 79, pp.522~528 (2001)
13. Frosst P, "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase", Nat Genet, 10, pp.111~113 (1995)
14. Friso S, "A common mutation in the 5,10-methylenetetrahydrofo-late reductase gene affects genomic DNA methylation through an interaction with folate status", Proc Natl Acad Sci USA, 99, pp.5606~5611 (2002)
15. Gilbody S, "Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review", Am J Epidemiol, 165, pp.1~13 (2007)
16. Lewis SJ, "A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk", Am J Med Genet B Neuropsychiatr Genet, 135B, pp.2~4 (2005)
17. Muntjewerff JW, "Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis", Mol Psychiatry, 11, pp.143~149 (2006)
18. Zintzaras E., "C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies", Psychiatr Genet, 16, pp.105~115 (2006)
19. Mudd SH, "Disorders of transsulfuration. In The metabolic and molecular bases of inherited disease", pp.2007~2056 (2001), McGraw-Hill
20. Sasaki M, "Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer", Cancer Res, 63, pp.3101~3106 (2003)
21. Abdolmaleky HM, "Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder", Hum Mol Genet, 15, pp.3132~3145 (2006)
22. Deth RC, "Molecular origins of human attention: the dopamine-folate connection" (2003), Springer-Verlag
23. Andreasen NC, "The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology", Arch Gen Psychiatry, 49, pp.615~623 (1992)
24. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (1994), American Psychiatric Press
25. Okochi T, "Meta-analysis of association between genetic variants in COMT and schizophrenia: an update", Schizophr Res, 110, pp.140~148 (2009)
26. Kremer I, "Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs", Am J Med Genet B Neuropsychiatr Genet, 119B, pp.35~39 (2003)
27. Arinami T, "Screening for 22q11 deletions in a schizophrenia population", Schizophr Res, 52, pp.167~170 (2001)
28. Galderisi S, "COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study", Schizophr Res, 73, pp.27~30 (2005)
29. Norton N, "Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis", Am J Med Genet, 114, pp.491~496 (2002)
30. Kim YR, "Catechol-O-methyltransferase Val158Met polymorphism in relation to aggressive schizophrenia in a Korean population", Eur Neuropsychopharmacol, 18, pp.820~825 (2008)
31. Liou YJ, "Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan", Neuropsychobiology, 43, pp.11~14 (2001)
32. Nunokawa A, "No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population", Neurosci Res, 58, pp.291~296 (2007)
33. Palmatier MA, "COMT haplotypes suggest P2 promoter region relevance for schizophrenia", Mol Psychiatry, 9, pp.859~870 (2004)
34. Chien YL, "Association of the 3′region of COMT with schizophrenia in Taiwan", J Formos Med Assoc, 108, pp.301~309 (2009)
35. Roffman JL, "Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia", Schizophr Res, 92, pp.181~188 (2007)
36. Meyer-Lindenberg A, "Impact of complex genetic variation in COMT on human brain function", Mol Psychiatry, 11, pp.867~877 (2006)
37. Roffman JL, "Interactive effects of COMT Val108", 158Met and MTHFR C677T on executive function in schizophrenia, 2008, pp.147B, 990~995

관련 논문AI추천